Completed PHASE3 INTERVENTIONAL 8-arm NCT02371759

Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2 (LCIOADMT2)

Efficacy and Safety of Intraoral Local Anesthesia by Lidocaine + Clonidine in Patients With Diabetes Mellitus Type 2

Sponsor: University of Belgrade

Conditions Diabetes Mellitus Local Anesthesia

Interventions L+C mandibular anesthesia L+C maxillary anesthesia L+E mandibular anesthesia L+E maxillary anesthesia

Updated 6 times since 2017 Last updated: Mar 22, 2017 Started: Jun 30, 2013 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Diabetes Mellitus and Local Anesthesia, this trial is completed. The trial is conducted by University of Belgrade and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jun 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2017 [monthly]

Completed PHASE3

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Belgrade

Data source: University of Belgrade

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Belgrade, Serbia